According to the company, the lens is the first and only FDA-approved EDOF IOL in the US without a warning regarding loss of contrast sensitivity. Johnson & Johnson announced that the US Food and Drug ...
Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients ...
Johnson & Johnson (NYSE: JNJ) announced that it received FDA approval for its Tecnis PureSee intraocular lens (IOL) for cataract surgery.
NEUCHATEL, Switzerland--(BUSINESS WIRE)--The company Swiss Advanced Vision (SAV-IOL SA) announced today the launch of LUCIDIS and EDEN, two new intraocular lenses (IOLs) for the cataract surgery, both ...
Johnson & Johnson (NYSE: JNJ) announced U.S. Food and Drug Administration (FDA) approval of TECNIS PureSee IOL, an extended depth of focus (EDOF) intraocular lens (IOL) intended for use in cataract ...
To allow ophthalmic surgeons and their patients to achieve optimal vision, the web-based configurator of Harmonis offers a set of selectable parameters for light distribution ratios of near, ...
Please provide your email address to receive an email when new articles are posted on . VIENNA — A clearer definition of what extended depth of focus lenses are or should be is needed because ...
FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof® IQ Vivity® and Clareon® Vivity ...
IRVINE, Calif., Sept. 28, 2022 /PRNewswire/ -- Johnson & Johnson Vision,** a global leader in eye health and part of Johnson & Johnson MedTech,*** today announced availability of our ...
Please provide your email address to receive an email when new articles are posted on . The ideal lens for our eyes is the one that we had in our youth. The young human crystalline lens provides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results